184 related articles for article (PubMed ID: 9219159)
21. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
22. Role of T cells in the mediation of Heymann nephritis. ii. Identification of Th1 and cytotoxic cells in glomeruli.
Penny MJ; Boyd RA; Hall BM
Kidney Int; 1997 Apr; 51(4):1059-68. PubMed ID: 9083271
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of steroids on leukocyte-mediated glomerulonephritis in the rabbit.
Holdsworth SR; Bellomo R
Kidney Int; 1984 Aug; 26(2):162-9. PubMed ID: 6503135
[TBL] [Abstract][Full Text] [Related]
24. CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis.
Wu J; Hicks J; Borillo J; Glass WF; Lou YH
J Clin Invest; 2002 Feb; 109(4):517-24. PubMed ID: 11854324
[TBL] [Abstract][Full Text] [Related]
25. Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient mice.
Wakayama H; Hasegawa Y; Kawabe T; Hara T; Matsuo S; Mizuno M; Takai T; Kikutani H; Shimokata K
Eur J Immunol; 2000 Apr; 30(4):1182-90. PubMed ID: 10760808
[TBL] [Abstract][Full Text] [Related]
26. FMS-like tyrosine kinase 3 ligand treatment does not ameliorate experimental rapidly progressive glomerulonephritis.
Ghali JR; O'Sullivan KM; Eggenhuizen PJ; Holdsworth SR; Kitching AR
PLoS One; 2015; 10(4):e0123118. PubMed ID: 25849330
[TBL] [Abstract][Full Text] [Related]
27. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice.
Le Hir M; Haas C; Marino M; Ryffel B
Lab Invest; 1998 Dec; 78(12):1625-31. PubMed ID: 9881962
[TBL] [Abstract][Full Text] [Related]
28. Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum.
Holdsworth SR; Neale TJ; Wilson CB
J Clin Invest; 1981 Sep; 68(3):686-98. PubMed ID: 7276168
[TBL] [Abstract][Full Text] [Related]
29. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.
Holdsworth SR; Tipping PG
J Clin Invest; 1985 Oct; 76(4):1367-74. PubMed ID: 4056035
[TBL] [Abstract][Full Text] [Related]
30. Immunologic determinants of susceptibility to experimental glomerulonephritis: role of cellular immunity.
Coelho SN; Saleem S; Konieczny BT; Parekh KR; Baddoura FK; Lakkis FG
Kidney Int; 1997 Mar; 51(3):646-52. PubMed ID: 9067895
[TBL] [Abstract][Full Text] [Related]
31. Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis.
Li M; O'Sullivan KM; Jones LK; Lo C; Semple T; Kumanogoh A; Kikutani H; Holdsworth SR; Kitching R
Immunology; 2009 Sep; 128(1):114-22. PubMed ID: 19689741
[TBL] [Abstract][Full Text] [Related]
32. Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis.
Suzuki Y; Shirato I; Okumura K; Ravetch JV; Takai T; Tomino Y; Ra C
Kidney Int; 1998 Oct; 54(4):1166-74. PubMed ID: 9767532
[TBL] [Abstract][Full Text] [Related]
33. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis.
Tang T; Rosenkranz A; Assmann KJ; Goodman MJ; Gutierrez-Ramos JC; Carroll MC; Cotran RS; Mayadas TN
J Exp Med; 1997 Dec; 186(11):1853-63. PubMed ID: 9382884
[TBL] [Abstract][Full Text] [Related]
34. Endogenous IL-13 limits humoral responses and injury in experimental glomerulonephritis but does not regulate Th1 cell-mediated crescentic glomerulonephritis.
Kitching AR; Turner AL; Wilson GR; Edgtton KL; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2004 Sep; 15(9):2373-82. PubMed ID: 15339986
[TBL] [Abstract][Full Text] [Related]
35. IL-4 is an endogenous inhibitor of neutrophil influx and subsequent pathology in acute antibody-mediated inflammation.
Saleem S; Dai Z; Coelho SN; Konieczny BT; Assmann KJ; Baddoura FK; Lakkis FG
J Immunol; 1998 Jan; 160(2):979-84. PubMed ID: 9551937
[TBL] [Abstract][Full Text] [Related]
36. IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis.
Kitching AR; Tipping PG; Kurimoto M; Holdsworth SR
J Immunol; 2000 Oct; 165(8):4649-57. PubMed ID: 11035108
[TBL] [Abstract][Full Text] [Related]
37. Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Pusey CD
J Am Soc Nephrol; 2001 Jan; 12(1):61-70. PubMed ID: 11134251
[TBL] [Abstract][Full Text] [Related]
38. CD4+ T cells recognizing specific antigen deposited in glomeruli cause glomerulonephritis-like kidney injury.
Radeke HH; Tschernig T; Karulin A; Schumm G; Emancipator SN; Resch K; Tary-Lehmann M
Clin Immunol; 2002 Aug; 104(2):161-73. PubMed ID: 12165277
[TBL] [Abstract][Full Text] [Related]
39. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
Phoon RK; Kitching AR; Jones LK; Holdsworth SR
Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
[TBL] [Abstract][Full Text] [Related]
40. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.
Kovalenko P; Fujinaka H; Yoshida Y; Kawamura H; Qu Z; El-Shemi AG; Li H; Matsuki A; Bilim V; Yaoita E; Abo T; Uchiyama M; Yamamoto T
Int Immunol; 2004 May; 16(5):625-34. PubMed ID: 15096492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
